Federal regulations that have allowed practitioners the flexibility to virtually prescribe buprenorphine, an opioid withdrawal treatment drug, are due to expire along with the COVID-19 public health emergency — even as opioid deaths reach record levels. Krista Mahr reports for Politico.
